Skip to content
Credit reportVerdict and grounds
Made on 21-11-2026 at 03:26
Reference CK-0401994823-20261121

Pfizer

ActivePublic limited company0401.994.823Pleinlaan 17, 1050 Ixelles
Wholesale of pharmaceutical and medical goods (NACE 46460) · founded in 1954 · 4th largest employer in Ixelles, Wholesale and retail trade sector · 3 establishment units · financial year to 30 November

Sources: the KBO register on 21-11-2026; the National Bank, annual accounts to 30-11-2025 filed on 02-06-2026; the Belgian Official Gazette, latest deed of 04-08-2026.

Credit verdict
No verdict
No credit verdict on the figures available
  • Base your decision on your own payment experience with the company or on securities.
Checked score
No score
Too few figures to score.
Bankruptcy probability within 12 months
The median of 147 large companies in the wholesale trade sector (NACE 46) is 0.3%.
Turnover
€358.3m
▲ 6.5% against 2024
Net result
€3.7m
▼ 84.2% against 2024
Equity
-
Supplier credit
40 days
67 days shorter than in 2024

Grounds

the facts the verdict rests on, each with its source
  1. In the year to 30-11-2025, Pfizer had a turnover of €358.3m and a net profit of €3.7m.Annual accounts to 30-11-2025 page 2
  2. Suppliers waited 40 days on average for their money in the year to 30-11-2025, 67 days shorter than in the year to 30-11-2024. Customers paid after 126 days.Annual accounts to 30-11-2024 and to 30-11-2025 page 2
  3. The last five annual accounts came in on time. The accounts to 30-11-2025 were filed 28 days before the end of the term.National Bank, filing of 02-06-2026 page 5

Representation

Two directors jointly represent Pfizer. The directors are , and .

Articles of association, Belgian Official Gazette of 19-01-2026, deed 26007992

Ownership

. includes Pfizer in its consolidated accounts. According to the deed of 10-07-2019, . holds all the shares.

LEI register, deed 19091888

Pfizer · 0401.994.823 · credit report of 21-11-2026Page 1 of 6
Pfizer0401.994.823 · report of 21-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Turnover and net resultin €m

2021469.52022548.22023349.42024336.52025358.3202119.5202221.6202312.9202423.220253.7
turnovernet result

Equity and debtsin €m

20212022202320242025226.6
equitydebts

Payment termsin days

3060901201501802021202220232024202540126
suppliers waitcustomers pay
Financial year20212022202320242025Trend
Results
Turnover€469.5m€548.2m€349.4m€336.5m€358.3m
Operating result€27.1m€29.8m€20.7m€36.2m€15.1m
Net result€19.5m€21.6m€12.9m€23.2m€3.7m
Balance sheet at the closing date
Equity€118.8m€90.4m---
Debts€132.2m€183.5m€275.7m€346.0m€226.6m
Debts due within one year€130.1m€182.6m€249.2m€338.4m€224.7m
Cash€40.7m€724,690€21.9m€21.3m€23.9m
Balance sheet total€254.7m€285.3m€383.4m€474.6m€377.4m
Operations
Employees in full-time equivalents333.4336.3338.2323.0297.0
Customer credit85 days91 days179 days175 days126 days
Supplier credit54 days19 days7 days107 days40 days
Ratios
Solvency46.7%31.7%---
Liquidity1.881.501.491.371.63

Source: Annual accounts to 30-11-2025, full format, filed on 02-06-2026 (2026-00137670); Annual accounts to 30-11-2024, full format, filed on 23-05-2025 (2025-00110685); Annual accounts 2021 to 2023, filed from 01-06-2022 to 21-05-2024 (2022-20046669, 2023-00098666, 2024-00094385).

The operating result of 2025 is 58% lower than in 2024.

Debts fell by €119.4m in 2025.

The annual accounts to 30-11-2025 state no amount of overdue tax or social security (RSZ) debts.

Pfizer · 0401.994.823 · credit report of 21-11-2026Page 2 of 6
Pfizer0401.994.823 · report of 21-11-2026

Board, signature and ownership

Position on 21-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

Two directors jointly represent Pfizer. The directors are , and .

Articles of association, Belgian Official Gazette of 19-01-2026, deed 26007992

Board

three directors and one statutory auditor in office
Directorappointed by deed of 25-09-2013
deed of 25-09-2013
Director and managing directorappointed by deed of 19-01-2026
6-year term from 2026deed of 19-01-2026
Directorappointed by deed of 04-08-2026
6-year term from 2026deed of 04-08-2026
Statutory auditorappointed by deed of 13-07-2004
deed of 13-07-2004

Ownership and group

Shareholders

. includes Pfizer in its consolidated accounts. includes Pfizer in its consolidated accounts. According to the deed of 10-07-2019, . holds all the shares.

LEI register, annual accounts 30-11-2014, deed 19091888

Board changes

and resign. appointed. Discharge granted to . General meeting of 01-07-2026.

Gazette, deed 26099381

Power of attorney granted to . Board meeting of 13-01-2026.

Gazette, deed 26045964

New managing director. appointed, resigned. Discharge granted to . Board meeting of 24-11-2025.

Gazette, deed 26007992

(director) and (statutory auditor) reappointed. General meeting of 21-05-2025.

Gazette, deed 25080098

resigns as managing director. appointed as managing director. acts as permanent representative.

Gazette, deed 25037930

Powers of attorney granted to , and 7 others. Board meeting of 27-04-2023.

Gazette, deed 23068149
Pfizer · 0401.994.823 · credit report of 21-11-2026Page 3 of 6
Pfizer0401.994.823 · report of 21-11-2026

Holdings

Pfizer has 2 holdings (own accounts to 30-11-2014).

Country CompanyYear Equity Result
Belgium 2
BE 0.08%dissolved2021 €2.7m result -€23,058
BE 0.04%2014 €514,810 result -€5,729

Source: List of holdings in its own accounts to 30-11-2014. Holdings that file themselves stand with their latest accounts, the others with the amounts of that list, in their own currency.

Pfizer · 0401.994.823 · credit report of 21-11-2026Page 4 of 6
Pfizer0401.994.823 · report of 21-11-2026

Events and comparison

The latest events, newest first

Annual accounts 2025 filed, 28 days before the deadline.

NBB filing

Annual accounts 2024 filed, 38 days before the deadline.

NBB filing

Annual accounts 2023 filed, 40 days before the deadline.

NBB filing

Annual accounts 2022 filed, 38 days before the deadline.

NBB filing

New managing director. appointed, resigned. General meeting of 03-10-2022.

Gazette, deed 22142900

reappointed as statutory auditor. General meeting of 10-06-2022.

Gazette, deed 22099635

Annual accounts 2021 filed, 29 days before the deadline.

NBB filing

resigns. and appointed. General meeting of 18-05-2021. Published again on 26-08-2021.

Gazette, deed 21092974

Annual accounts 2020 filed, 30 days before the deadline.

NBB filing

Annual accounts 2019 filed, 1 day before the deadline.

NBB filing

Amendment of the articles. Auditor report: €56,018,500. Capital of €39,688,620.47, 216,166 shares. General meeting of 30-04-2020.

Gazette, deed 20322673

General meeting of 21-01-2020. Published again on 11-03-2020.

Gazette, deed 20027504

. holds all the shares.

Gazette, deed 19091888

, , and (statutory auditor). acts as permanent representative. General meeting of 15-05-2019.

Gazette, deed 19079915

The return on assets of Pfizer, 1.0%, is higher than at 29% of the 3,801 companies filing full accounts in wholesale trade (NACE 46) in 2025.

Other findings

Peppol

Reachable for e-invoices since 14-10-2025, under 0208:0401994823.

Sanctions lists

Pfizer · 0401.994.823 · credit report of 21-11-2026Page 5 of 6
Pfizer0401.994.823 · report of 21-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units21-11-2026KBO 0401.994.823
National Bank of BelgiumAnnual accounts to 30-11-2025, full format02-06-20262026-00137670
National Bank of BelgiumAnnual accounts to 30-11-2024, full format23-05-20252025-00110685
National Bank of BelgiumAnnual accounts 2021 to 202301-06-2022 to 21-05-20242022-20046669, 2023-00098666, 2024-00094385
Belgian Official GazetteBoard04-08-2026deed 26099381
Belgian Official GazetteBoard02-04-2026deed 26045964
Belgian Official GazetteArticles of association with the signing rule19-01-2026deed 26007992
Belgian Official GazetteAll shares held by one shareholder10-07-2019deed 19091888
Peppol DirectoryRegistration for e-invoices14-10-20250208:0401994823
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies20-11-2026bankruptcy model of 2 October 2026

Method

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.

Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.

The scores and ratios are Checked's own calculations, not a credit decision.

Pfizer · 0401.994.823 · credit report of 21-11-2026Page 6 of 6